The rating revision is based on several factors, including BHS’ growing patient volume, dominant market share and healthy cashflow margins.
“The stable outlook reflects our view that BHS has maintained solid enterprise and financial profiles in recent years, in line with our expectations,” said S&P credit analyst Jennifer Soule.
Though unlikely, a lower rating or negative outlook may be possible if BHS’ net patient revenue declines or accumulates excessive debt.
More hospital outlook and credit rating actions:
Fitch upgrades Holy Redeemer Health System’s bonds to ‘BBB’
S&P assigns ‘A-‘ rating to Nacogdoches County Hospital District’s bonds
Moody’s downgrades Good Samaritan Hospital’s rating to ‘Baa2’
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
